22.11.2014 Views

Programme (PDF) - (NCRI) Cancer Conference 2013 - National ...

Programme (PDF) - (NCRI) Cancer Conference 2013 - National ...

Programme (PDF) - (NCRI) Cancer Conference 2013 - National ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

o Henrik Møller<br />

King's College London, UK<br />

Intensity of radical resection for lung cancer in relation to survival<br />

outcomes in England<br />

o Alex Chacko<br />

Queen’s University Belfast, UK<br />

The mitochondrial ATP transporter VDAC1 /Porin is required for<br />

TRAIL-induced apoptosis in non-small cell lung cancer<br />

New strategies for improving prognosis in breast cancer<br />

Hosted by Ian Smith<br />

The Institute of <strong>Cancer</strong> Research and Royal Marsden Hospital, Sutton, UK<br />

o Ian Smith<br />

The Institute of <strong>Cancer</strong> Research and Royal Marsden Hospital, Sutton, UK<br />

Introduction<br />

o John Robertson<br />

University of Nottingham, UK<br />

Auto-antibodies in breast cancer: a new diagnostic tool?<br />

o Stephen Johnston<br />

The Institute of <strong>Cancer</strong> Research and Royal Marsden Hospital, Sutton, UK<br />

Combined targeted therapies in breast cancer<br />

o Robert Coleman<br />

Weston Park Hospital, University of Sheffield, UK<br />

Bone targeted therapy: modifying the soil to prevent metastatic<br />

seeding<br />

Proffered paper presentations:<br />

o Jason S Carroll<br />

University <strong>Cancer</strong> Research UK; Cambridge Research Institute, Cambridge,<br />

UK<br />

BACR/AstraZeneca Frank Rose Young Scientist Award<br />

Understanding how pioneer factors regulate Oestrogen receptor<br />

function in breast cancer cells<br />

o<br />

Darran O’Connor<br />

University College Dublin, Ireland<br />

The cocaine and amphetamine-regulated transcript (CART) is an<br />

independent prognostic factor in lymph node-negative breast<br />

cancer and predicts tamoxifen response<br />

o Neil Jelly<br />

University of Lincoln, UK<br />

Anti-stem cell factor enhances the effect of Anthracycline and<br />

Taxane chemotherapy in chemoresistant breast cancer cell<br />

lines<br />

15

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!